WIReD: Wireless Interstage Remote Device Study

Sponsor
Children's Mercy Hospital Kansas City (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05975658
Collaborator
Gabi SmartCare (Industry)
15
1
11.6
1.3

Study Details

Study Description

Brief Summary

A mixed-methods study will be used to evaluate the use of standard of care periodic pulse oximetry by parents/LAR and the feasibility of the collection of physiologic data related to the use of the Pediarity System. This system includes the Gabi Band and software platform (Gabi Analytics).

Condition or Disease Intervention/Treatment Phase
  • Device: Gabi SmartCare Pediarity System [Gabi Band, Gabi Monitor App, Gabi Analytics]

Detailed Description

After enrollment, parents will be taught by the study team on the use of the Pediarity System which includes the placement of the Gabi Band and the use of the Gabi Wi-Fi monitor application for data transfer. This education by the study team will ensure uniform training and preliminary understanding with teach back on the use of the Gabi band and Gabi Wi-Fi monitoring application. Parents can ask the study team any use and/or technical questions during this time period. All clinical care questions from standard of care monitoring will go to the CHAMP healthcare team. If parents/LARs have a clinical concern from a value on the Pediarity System - they will be referred to use their standard of care pulse oximetry before any clinical intervention and care is recommended by the healthcare team. The study team will not make any healthcare or diagnostic recommendations during the monitoring period based on any Pediarity System data.

The study team will educate parents and LARs on the Pediarity System. This system does not replace any use of their standard of care pulse oximetry and CHAMP videos. Parents may place the Gabi band on their child and use the Pediarity System at any frequency they choose in the home setting for a length of approximately one month at home (to coordinate when they return to the study site for a care visit). Parents can email or Teams call the study team directly (during daytime hours M-F) for any technical questions during this the study period. The study team will evaluate clinical data only at the conclusion of the study period and qualitative feedback from the parents will be gathered.

Study Design

Study Type:
Observational
Anticipated Enrollment :
15 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
WIReD: Wireless Interstage Remote Device Study
Anticipated Study Start Date :
Aug 15, 2023
Anticipated Primary Completion Date :
Jan 31, 2024
Anticipated Study Completion Date :
Aug 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Parental Experience Evaluation [3-6 Weeks]

    Rigorously explore the parental experience of utilizing a continuous pediatric wireless device for monitoring at home pulse oximetry compared with standard of care periodic pulse oximetry.

Secondary Outcome Measures

  1. Data Transfer Rate Evaluation [3-6 Weeks]

    Evaluate the rate of data transfer from a wireless continuous monitoring device night ± daytime vs. standard of care periodic pulse oximetry.

  2. Stakeholder Experience Assessment [3-6 Weeks]

    Assess the technology experience for stakeholders with a wireless continuous monitoring device at home vs. standard of care periodic pulse oximetry.

  3. Data Threshold Event Rate Evaluation [3-6 Weeks]

    Evaluate the rate of data threshold events with continuous remote device monitoring at home vs. intermittent pulse oximetry via standard of care periodic pulse oximetry.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 2 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Study participants will be parent-child dyads - pediatric patients who have been diagnosed with congenital, arrhythmic, or acquired heart disease at Children's Mercy Kansas City.

  • Age criteria for children: after birth and who are less than two years of age at the time of being approached.

  • Age criteria for parents or legally authorized representatives (LAR's): one participating parent or LAR will be 18 years of age or older to consent at the time of being approached

  • The child of the parent-child dyad must be planned from the clinical standpoint prior to approach for discharge home with standard of care oxygen saturation/heart rate/pulse oximeter for remote patient monitoring population - and followed with the CHAMP application in the home setting.

  • CHAMP App CM IRB 15030113 - Pediatric patients must be utilizing the CHAMP app clinically

Exclusion Criteria:
  • Over two years of age at the time of being approached for study participation.

  • A child with no parents or LAR over age of 18 at the time the study team would approach the family.

  • Non-English-speaking families.

  • Families that do not have access to a Wi-Fi network at home.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Mercy Hospital Kansas City Missouri United States 64108

Sponsors and Collaborators

  • Children's Mercy Hospital Kansas City
  • Gabi SmartCare

Investigators

  • Principal Investigator: Lori Erickson, PhD, Director, Remote Health Solutions Children's Mercy

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Lori Erickson, Director, Remote Health Solutions, Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier:
NCT05975658
Other Study ID Numbers:
  • STUDY00002554
First Posted:
Aug 4, 2023
Last Update Posted:
Aug 4, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Lori Erickson, Director, Remote Health Solutions, Children's Mercy Hospital Kansas City
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2023